Reaction

Product Monitoring Error reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,416 reports · 66 co-occurring drugs

As of the last recalculation, Product Monitoring Error appears in 1,416 FAERS reports alongside 66 co-occurring drug terms. The strongest observed disproportionality signal is TORSEMIDE (PRR 165.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Torsemide	295	165.1	166.6
Candesartan	188	89.2	89.6
Insulin Glargine-Yfgn	61	42.8	42.9
Ramipril	232	32.7	32.8
Nebivolol	33	31.2	31.2
Niraparib	38	25.8	25.9
Metoprolol Tartrate Injection	270	25.6	25.7
Telmisartan	30	25.2	25.3
Allopurinol	217	23.9	23.9
Bisoprolol Fumarate	190	23.6	23.6
Moxifloxacin	22	23.3	23.3
Amphetamine	12	21.5	21.5
Sitagliptin	98	21.4	21.4
Moxifloxacin Hydrochloride	27	19.9	20.0
Pantoprazole Sodium In 0.9% Sodium Chloride	79	19.8	19.8
Pantoprazole Sodium Injection	79	19.8	19.8
Levothyroxine Sodium Anhydrous	123	19.7	19.7
Metoprolol	276	19.6	19.6
Apixaban	80	18.6	18.6
Bicalutamide	19	18.6	18.6
Metoprolol Tartrate	276	18.2	18.2
Cefuroxime	14	18.2	18.2
Pantoprazole	257	18.0	18.0
Dalteparin Sodium	12	16.8	16.8
Rifampicin	11	16.1	16.1
Nebivolol Hydrochloride	34	15.1	15.2
Empagliflozin	66	15.1	15.1
Insulin Glulisine	10	14.6	14.6
Simvastatin	209	14.2	14.2
Indapamide	17	14.1	14.1
Spironolactone	122	13.9	13.9
Bisacodyl Suppositories	12	13.7	13.8
Biscodyl	12	13.6	13.6
Mirtazapine	79	13.4	13.4
Clopidogrel Bisulfate	85	12.9	12.9
Doxazosin	24	12.8	12.8
Bisacodyl	12	12.6	12.6
Candesartan Cilexetil	22	12.5	12.5
Carvedilol	99	11.5	11.5
Chlorthalidone	9	11.5	11.5
Calcitriol Capsules 0.25 Mcg	15	11.1	11.1
Calcitriol Capsules 0.5 Mcg	15	11.1	11.1
Calcitriol	15	11.0	11.0
Duloxetine	50	10.9	10.9
Nicotine Polacrilex Mini	11	10.9	10.9
Nicotine Polarilex	11	10.9	10.9
Crizotinib	9	10.5	10.5
Minoxidil Foam 5% (Womens)	23	10.4	10.4
Eplerenone	9	10.4	10.4
Oxazepam	15	10.4	10.4
Brinzolamide	6	10.2	10.2
Doxazosin Mesylate	24	9.9	9.9
Metformin Er 500 Mg	178	9.8	9.8
Metformin Er 750 Mg	178	9.8	9.8
Acalabrutinib	8	9.8	9.8
Insulin Human	25	9.4	9.4
Minoxidil	23	7.6	7.6
Rivaroxaban	100	7.5	7.5
Dapagliflozin	15	7.1	7.1
Sevelamer Carbonate	4	5.1	5.1
Sacubitril And Valsartan	33	4.3	4.3
Tapentadol Hydrochloride	9	4.0	4.0
Dulaglutide	22	3.7	3.7
Drospirenone And Ethinyl Estradiol	11	3.7	3.7
Aflibercept	6	2.8	2.8
Levonorgestrel	33	2.4	2.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.